CSL Ltd

Type: Company
Name: CSL Ltd
First reported 22 hours ago - Updated 22 hours ago - 1 reports

MARKET COMMENT: S&P/ASX 200 Recovery May Continue Pre-FOMC Outcome

2350 GMT [Dow Jones] Australia's S&P/ASX 200 is poised to continue recovering before a two-day FOMC meeting concludes Wednesday, with U.S. equities, iron ore and crude oil providing positive leads for the Australian market. IG strategist Evan Lucas tips ... [Published 4 Traders - 22 hours ago]
First reported 22 hours ago - Updated 22 hours ago - 1 reports

CSL LIMITED: - Changes to Segment Reporting

CSL Limited - Changes to Segment ReportingMelbourne, Australia - 19/06/2013In February 2013, the Company announced the completion of the reorganisation of its Australian Operations which took effect from 1 January 2013 and advised that financial reporting ... [Published 4 Traders - 22 hours ago]
First reported Jun 18 2013 - Updated Jun 18 2013 - 1 reports

Slow start to flu season

Australia is experiencing an unusual lull in influenza cases for winter, but a peak is still expected in August or September, experts say.Latest figures from the Communicable Diseases Network show influenza activity is stable and there has not yet been ... [Published Australian Doctor - Jun 18 2013]
First reported Jun 18 2013 - Updated Jun 18 2013 - 1 reports

CSL managing director in the spotlight

With less than two weeks to go until the long-time managing director of blood plasma group CSL$ (ASX: CSL) Brian McNamee hangs up his lab coat and retires, The Australian Financial Review has reported on an outstanding tenure that saw McNamee take “CSL ... [Published NineMSN Finance - Jun 18 2013]
First reported Jun 17 2013 - Updated Jun 17 2013 - 1 reports

Exit the King: McNamee's mastery

Who has been the best Australian chief executive over the last quarter of a century?Traditionally the men who built BHP – Essington Lewis and Ian McLennan – plus Rupert Murdoch have been seen as clearly our best.The BHP leaders came from a different era ... [Published Business Spectator - Jun 17 2013]
First reported Jun 16 2013 - Updated Jun 16 2013 - 1 reports

Innovate or decline: McNamee

CSL CEO Brian McNamee has warned that Australia must become more productive and competitive if it is to successfully progress from an economy based on resources. He said that Australia needs to move to high-end manufacturing, and this requires innovation ... [Published Individual.com - Jun 16 2013]
First reported Jun 16 2013 - Updated Jun 16 2013 - 1 reports

McNamee signs off at CSL

Brian McNamee will step down as CEO of blood plasma company CSL at the end of June 2013, after 23 years in the job. CSL, which began life as the Commonwealth Serums Laboratories in 1916, was only worth $A23 million when McNamee became CEO, but it is now ... [Published Individual.com - Jun 16 2013]
First reported Jun 16 2013 - Updated Jun 16 2013 - 1 reports

June 16 transcript: CSLs McNamee

View Full Quote »View All Announcements Deborah Knight: One of Australias best performing CEOs, Dr Brian McNamee, says farewell to colleagues and shareholders next week after 23 years running medical giant CSL. He has an enviable record in delivering ... [Published Australian Financial Review - Jun 16 2013]
First reported Jun 14 2013 - Updated Jun 14 2013 - 1 reports

Australia shares rebound in biggest one-day gain since April

(Adds details, comments, stocks on the move)SYDNEY, June 14 (Reuters) - Australian shares rebounded 1.3 percent on Friday, their biggest one-day gain since April, as high-yielding stocks including flagship financials underpinned the local market and Wall ... [Published Yahoo! UK and Ireland - Jun 14 2013]
First reported Jun 14 2013 - Updated Jun 14 2013 - 1 reports

CSL buy-back continues as share price falls

Leading blood plasma group CSL$ (ASX: CSL) has been making the most of the recent fall in its share price with continued on market purchases of its shares. Since the latest buy-back was implemented in October 2012 over 14 million shares have been re-purchased ... [Published NineMSN Finance - Jun 14 2013]
First reported Jun 13 2013 - Updated Jun 13 2013 - 1 reports

CSL Behring doses first patient in Part 3 of Phase III hemophilia A study

CSL Behring, a plasma protein biotherapeutics company, has dosed the first patient in Part 3 of the company's AFFINITY clinical trial program, which is now in Phase III. AFFINITY is an open-label, non-randomized multi-center study evaluating the efficacy, ... [Published Individual.com - Jun 13 2013]
First reported Jun 13 2013 - Updated Jun 13 2013 - 1 reports

Australia shares fall to fresh 5-1/2-mth low, local jobs data eyed

Entrance interior of the Australian Securities Exchange (Adds market performance details, analyst comments, stocks on the move) SYDNEY, June 13 (Reuters) - Australian shares fell 0.9 percent in late morning trade on Thursday to hit a 5-1/2-month low as ... [Published Sharenet - Jun 13 2013]

Quotes

"We started to supply these additional doses at the end of May. It is our understanding that there are no supply issues at present" a spokeswoman said
"If we see the market hold up nicely through to the close today, above 50 points, I'd say that it's a sign that confidence is returning into the Australian market and we can see an upside to the next week or so" Radford said
...-SingleChain molecule with the hemophilia community in the future," said Russell Basser, M D , CSL SeniorSenior vice president, Global Clinical R&D. "As part of our ongoing commitment to the hemophilia community, we are developing and investigating innovative recombinant factor therapies for the treatment of both hemophilia A and B that have the potential to offer patients and caregivers significant advances in treatment and convenience of factor infusion." CSL Behring, in collaboration with its parent company, CSL Limited (ASX: CSL), is developing rVIII-SingleChain through the AFFINITY clinical trial p...
...The S&P/ASX 200 index dropped 43.1 points to 4,681.4 by 0114 GMT, its lowest level since January 2. The benchmark fell 0.7 percent on Wednesday. "The selloff is over-extended, and they (investors) will wait for the opportunity to take advantage of this selloff" Radford said. Top miners weighed on the market, as BHP Billiton Ltd and Rio Tinto Ltd dropped 2.2 percent and 1.6 percent respectively...

More Content

All (64) | News (55) | Reports (0) | Blogs (4) | Audio/Video (0) | Fact Sheets (3) | Press Releases (2)
sort by: Date | Relevance
MARKET COMMENT: S&P/ASX 200 Recovery May Contin... [Published 4 Traders - 22 hours ago]
CSL LIMITED: - Changes to Segment Reporting [Published 4 Traders - 22 hours ago]
Slow start to flu season [Published Australian Doctor - Jun 18 2013]
CSL managing director in the spotlight [Published NineMSN Finance - Jun 18 2013]
FN Arena Broker Call Headlines - 17 Jun 2013 [Published NineMSN Finance - Jun 17 2013]
Exit the King: McNamee's mastery [Published Business Spectator - Jun 17 2013]
McNamee signs off at CSL [Published Individual.com - Jun 16 2013]
Innovate or decline: McNamee [Published Individual.com - Jun 16 2013]
June 16 transcript: CSLs McNamee [Published Australian Financial Review - Jun 16 2013]
CSL buy-back continues as share price falls [Published NineMSN Finance - Jun 14 2013]
Australia shares rebound in biggest one-day gai... [Published Yahoo! UK and Ireland - Jun 14 2013]
CSL Behring doses first patient in Part 3 of Ph... [Published Individual.com - Jun 13 2013]
Australia shares fall to fresh 5-1/2-mth low, l... [Published Sharenet - Jun 13 2013]
Sanofi's Quadrivalent Fluzone to Earn Up to $38... [Published FiercePharma - Jun 12 2013]
Australia shares sole gainers among Asia equiti... [Published Sharenet - Jun 11 2013]
Stocks rise amid strong Virtus debut [Published Brisbane Times - Jun 11 2013]
Stocks rise amid strong Virtus debut [Published WA Today - Jun 11 2013]
Australia shares climb, track other markets aft... [Published Sharenet - Jun 11 2013]
Australia shares edge up on offshore gains duri... [Published Big News Network - Jun 11 2013]
Australia shares edge up on offshore gains duri... [Published Sharenet - Jun 11 2013]
Out of your comfort zone [Published TradingCharts.com - Jun 10 2013]
Speech: In Kerala we find new UK-India partners... [Published Cabinet Office - Jun 07 2013]
Australia shares fall to new 4-1/2 mth low; cau... [Published Sharenet - Jun 06 2013]
Australia shares fall to 4-1/2 mth low on Fed s... [Published Sharenet - Jun 06 2013]
Should you buy CSL? [Published NineMSN Finance - Jun 06 2013]
Australia shares fall to 5-month lows on weaker... [Published Yahoo! UK and Ireland - Jun 05 2013]
Timing it right [Published Australian Life Scientist - Jun 05 2013]
ASX breaks three-day losing run [Published WA Today - Jun 04 2013]
Australia shares edge higher as RBA holds rates... [Published Reuters UK - Jun 04 2013]
Diversified Events Hong Kong to Produce Retail ... [Published Individual.com - Jun 04 2013]
1 2 3
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Hong Kong's CSL upgrades to LTE Cat 4 network, ... [Published Engadget - May 23 2013]
With Hong Kong boasting pretty much the fastest average internet speed on this planet, it's no surprise that the city is also one of the first to launch commercial 150Mbps LTE Cat 4 service -- just right after SingTel's launch in Singapore earlier this ...
Deal Of The Week: Nyet! [Published The IN VIVO Blog - Apr 19 2013]
The Russian government’s announcement on April 19 that its ministry of foreign investment has rejected Abbott Laboratories Inc.’s plans to buy a domestic vaccine manufacturer, NGO Petrovax Pharm , highlights the nuances and complexities of deal making ...
Australia shares down 0.5 pct; caution sets in ... [Published AdBanks.net - Mar 04 2013]
Posted on Mar 4, 2013 01:23:00 GMT …Rio Tinto dropped 2.1 percent. Most big banks advanced, led by National Australia Bank Ltd which added 0.8 percent. Westpac Banking Corp lost 0.6 percent. Defensive stocks were stronger as investors ...
Locked iPhone Sales Challenged in Hong Kong [Published Infoseekchina - Feb 22 2013]
Source : Wall Street Journal By Te-Ping Chen and Jeffrey Ng HONG KONG—The battle over sales of locked Apple Inc. iPhones has reached Hong Kong after a local telecommunications company filed court documents this week seeking to contest the practice. ...
1

Press Releases

sort by: Date | Relevance
Xencor Licenses Xtend™ Therapeutic Protein Half... [Published PR Newswire: Health - Apr 16 2013]
Key patent awarded to Adjuvance co-founders for... [Published PR Newswire - Nov 14 2012]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2013 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.